SMTL ID : 4fnz.1

Crystal structure of human anaplastic lymphoma kinase in complex with piperidine-carboxamide inhibitor 2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x NZF: (3S)-N-[3-(trifluoromethoxy)benzyl]-1-{2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}piperidine-3-carboxamide(Non-covalent)

NZF.1: 21 residues within 4Å: Chain A: L.39, V.47, A.65, K.67, E.84, I.88, F.91, I.96, V.97, L.113, E.114, M.116, A.117, G.119, D.120, H.164, L.173, I.185, G.186, D.187, F.188 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:A.65, A:I.88, A:I.88, A:I.88, A:I.96, A:V.97, A:L.173, A:F.188 Hydrogen bonds: A:M.116, A:M.116, A:G.186, A:D.187 Halogen bonds: A:I.185, A:D.187

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Epstein, L.F. et al., The R1275Q Neuroblastoma Mutant and Certain ATP-competitive Inhibitors Stabilize Alternative Activation Loop Conformations of Anaplastic Lymphoma Kinase. J.Biol.Chem. (2012)

Release Date

2012-08-29

Peptides

ALK tyrosine kinase receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK tyrosine kinase receptor

Related Entries With Identical Sequence